UniProt ID | RS16_HUMAN | |
---|---|---|
UniProt AC | P62249 | |
Protein Name | 40S ribosomal protein S16 | |
Gene Name | RPS16 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 146 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MPSKGPLQSVQVFGRKKTATAVAHCKRGNGLIKVNGRPLEMIEPRTLQYKLLEPVLLLGKERFAGVDIRVRVKGGGHVAQIYAIRQSISKALVAYYQKYVDEASKKEIKDILIQYDRTLLVADPRRCESKKFGGPGARARYQKSYR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MPSKGPLQSV -----CCCCCCCCEE | 49.28 | 29632367 | |
4 | Methylation | ----MPSKGPLQSVQ ----CCCCCCCCEEE | 59.69 | 21671283 | |
4 | Sumoylation | ----MPSKGPLQSVQ ----CCCCCCCCEEE | 59.69 | - | |
4 | Ubiquitination | ----MPSKGPLQSVQ ----CCCCCCCCEEE | 59.69 | 21890473 | |
4 | Malonylation | ----MPSKGPLQSVQ ----CCCCCCCCEEE | 59.69 | 26320211 | |
4 | 2-Hydroxyisobutyrylation | ----MPSKGPLQSVQ ----CCCCCCCCEEE | 59.69 | - | |
4 | Sumoylation | ----MPSKGPLQSVQ ----CCCCCCCCEEE | 59.69 | - | |
9 | Phosphorylation | PSKGPLQSVQVFGRK CCCCCCCEEEEECCC | 23.38 | 30266825 | |
15 | Methylation | QSVQVFGRKKTATAV CEEEEECCCCCEEHH | 26.32 | 115492463 | |
20 | Phosphorylation | FGRKKTATAVAHCKR ECCCCCEEHHHHCCC | 27.22 | 24888630 | |
25 | S-palmitoylation | TATAVAHCKRGNGLI CEEHHHHCCCCCCEE | 2.01 | 21044946 | |
25 | S-nitrosylation | TATAVAHCKRGNGLI CEEHHHHCCCCCCEE | 2.01 | 2212679 | |
26 | Acetylation | ATAVAHCKRGNGLIK EEHHHHCCCCCCEEE | 54.17 | 25953088 | |
26 | 2-Hydroxyisobutyrylation | ATAVAHCKRGNGLIK EEHHHHCCCCCCEEE | 54.17 | - | |
26 | Ubiquitination | ATAVAHCKRGNGLIK EEHHHHCCCCCCEEE | 54.17 | - | |
33 | Ubiquitination | KRGNGLIKVNGRPLE CCCCCEEEECCEECC | 34.39 | 21906983 | |
33 | Acetylation | KRGNGLIKVNGRPLE CCCCCEEEECCEECC | 34.39 | 26051181 | |
41 | Sulfoxidation | VNGRPLEMIEPRTLQ ECCEECCCCCCCCHH | 5.76 | 21406390 | |
45 | Methylation | PLEMIEPRTLQYKLL ECCCCCCCCHHHHHH | 34.97 | 115492479 | |
50 | Ubiquitination | EPRTLQYKLLEPVLL CCCCHHHHHHHHHHH | 33.37 | 21890473 | |
50 | Sumoylation | EPRTLQYKLLEPVLL CCCCHHHHHHHHHHH | 33.37 | - | |
50 | Acetylation | EPRTLQYKLLEPVLL CCCCHHHHHHHHHHH | 33.37 | 25825284 | |
50 | 2-Hydroxyisobutyrylation | EPRTLQYKLLEPVLL CCCCHHHHHHHHHHH | 33.37 | - | |
50 | Sumoylation | EPRTLQYKLLEPVLL CCCCHHHHHHHHHHH | 33.37 | - | |
60 | 2-Hydroxyisobutyrylation | EPVLLLGKERFAGVD HHHHHHCCCEECCCE | 45.76 | - | |
60 | Ubiquitination | EPVLLLGKERFAGVD HHHHHHCCCEECCCE | 45.76 | 21890473 | |
60 | Acetylation | EPVLLLGKERFAGVD HHHHHHCCCEECCCE | 45.76 | 19608861 | |
60 | Succinylation | EPVLLLGKERFAGVD HHHHHHCCCEECCCE | 45.76 | 23954790 | |
62 | Methylation | VLLLGKERFAGVDIR HHHHCCCEECCCEEE | 30.15 | 115492447 | |
69 | Methylation | RFAGVDIRVRVKGGG EECCCEEEEEEECCC | 13.01 | 115492455 | |
73 | Ubiquitination | VDIRVRVKGGGHVAQ CEEEEEEECCCCHHH | 41.07 | - | |
73 | Sumoylation | VDIRVRVKGGGHVAQ CEEEEEEECCCCHHH | 41.07 | - | |
73 | Sumoylation | VDIRVRVKGGGHVAQ CEEEEEEECCCCHHH | 41.07 | - | |
82 | Phosphorylation | GGHVAQIYAIRQSIS CCCHHHHHHHHHHHH | 5.49 | 20090780 | |
87 | Phosphorylation | QIYAIRQSISKALVA HHHHHHHHHHHHHHH | 20.98 | 30622161 | |
89 | Phosphorylation | YAIRQSISKALVAYY HHHHHHHHHHHHHHH | 19.68 | 30622161 | |
90 | Acetylation | AIRQSISKALVAYYQ HHHHHHHHHHHHHHH | 44.03 | 25953088 | |
90 | Ubiquitination | AIRQSISKALVAYYQ HHHHHHHHHHHHHHH | 44.03 | 21890473 | |
90 | 2-Hydroxyisobutyrylation | AIRQSISKALVAYYQ HHHHHHHHHHHHHHH | 44.03 | - | |
95 | Phosphorylation | ISKALVAYYQKYVDE HHHHHHHHHHHHCHH | 10.03 | 28152594 | |
96 | Phosphorylation | SKALVAYYQKYVDEA HHHHHHHHHHHCHHH | 6.70 | 28152594 | |
98 | Acetylation | ALVAYYQKYVDEASK HHHHHHHHHCHHHHH | 30.99 | 21466224 | |
98 | Ubiquitination | ALVAYYQKYVDEASK HHHHHHHHHCHHHHH | 30.99 | 21890473 | |
98 | 2-Hydroxyisobutyrylation | ALVAYYQKYVDEASK HHHHHHHHHCHHHHH | 30.99 | - | |
104 | O-linked_Glycosylation | QKYVDEASKKEIKDI HHHCHHHHHHHHHHH | 42.06 | 22121020 | |
105 | 2-Hydroxyisobutyrylation | KYVDEASKKEIKDIL HHCHHHHHHHHHHHH | 62.57 | - | |
105 | Acetylation | KYVDEASKKEIKDIL HHCHHHHHHHHHHHH | 62.57 | 25953088 | |
105 | Sumoylation | KYVDEASKKEIKDIL HHCHHHHHHHHHHHH | 62.57 | - | |
105 | Sumoylation | KYVDEASKKEIKDIL HHCHHHHHHHHHHHH | 62.57 | - | |
105 | Ubiquitination | KYVDEASKKEIKDIL HHCHHHHHHHHHHHH | 62.57 | - | |
106 | Ubiquitination | YVDEASKKEIKDILI HCHHHHHHHHHHHHH | 63.28 | - | |
109 | Ubiquitination | EASKKEIKDILIQYD HHHHHHHHHHHHHCC | 39.55 | 21890473 | |
109 | Succinylation | EASKKEIKDILIQYD HHHHHHHHHHHHHCC | 39.55 | 27452117 | |
109 | Acetylation | EASKKEIKDILIQYD HHHHHHHHHHHHHCC | 39.55 | 26822725 | |
109 | Sumoylation | EASKKEIKDILIQYD HHHHHHHHHHHHHCC | 39.55 | - | |
109 | Sumoylation | EASKKEIKDILIQYD HHHHHHHHHHHHHCC | 39.55 | - | |
109 | 2-Hydroxyisobutyrylation | EASKKEIKDILIQYD HHHHHHHHHHHHHCC | 39.55 | - | |
115 | Nitration | IKDILIQYDRTLLVA HHHHHHHCCCEEEEE | 10.61 | - | |
115 | Phosphorylation | IKDILIQYDRTLLVA HHHHHHHCCCEEEEE | 10.61 | 28152594 | |
117 | Methylation | DILIQYDRTLLVADP HHHHHCCCEEEEECH | 23.49 | 26494265 | |
125 | Methylation | TLLVADPRRCESKKF EEEEECHHHCCCCCC | 57.33 | 115492471 | |
129 | Phosphorylation | ADPRRCESKKFGGPG ECHHHCCCCCCCCCC | 44.78 | - | |
131 | 2-Hydroxyisobutyrylation | PRRCESKKFGGPGAR HHHCCCCCCCCCCHH | 59.53 | - | |
131 | Ubiquitination | PRRCESKKFGGPGAR HHHCCCCCCCCCCHH | 59.53 | - | |
131 | Acetylation | PRRCESKKFGGPGAR HHHCCCCCCCCCCHH | 59.53 | 25953088 | |
143 | Sumoylation | GARARYQKSYR---- CHHHHHHHHCC---- | 40.29 | - | |
143 | Sumoylation | GARARYQKSYR---- CHHHHHHHHCC---- | 40.29 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RS16_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RS16_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RS16_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-60, AND MASS SPECTROMETRY. |